Proceedings of ESPGHAN Monothematic Conference 2020: "Acute Liver Failure in Children": Diagnosis and Initial Management.
Journal
Journal of pediatric gastroenterology and nutrition
ISSN: 1536-4801
Titre abrégé: J Pediatr Gastroenterol Nutr
Pays: United States
ID NLM: 8211545
Informations de publication
Date de publication:
01 Mar 2022
01 Mar 2022
Historique:
entrez:
28
2
2022
pubmed:
1
3
2022
medline:
3
5
2022
Statut:
ppublish
Résumé
The Hepatology Committee of the European Society for Pediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) aims to educate pediatric gastroenterologists, members of ESPGHAN and professionals from other specialties promoting an exchange of clinical expertise in the field of pediatric hepatology. Herewith we have concentrated on detailing the recent advances in acute liver failure in infants and children. The 2020 ESPGHAN monothematic three-day conference on pediatric hepatology disease, entitled "acute liver failure" (ALF), was organized in Athens, Greece. ALF is a devastating disease with high mortality and most cases remain undiagnosed. As knowledge in diagnosis and treatment of ALF in infants and children has increased in the past decades, the objective was to update physicians in the field with the latest research and developments in early recognition, curative therapies and intensive care management, imaging techniques and treatment paradigms in these age groups. In the first session, the definition, epidemiology, various causes of ALF, in neonates and older children and recurrent ALF (RALF) were discussed. The second session was dedicated to new aspects of ALF management including hepatic encephalopathy (HE), coagulopathy, intensive care interventions, acute on chronic liver failure, and the role of imaging in treatment and prognosis. Oral presentations by experts in various fields are summarized highlighting key learning points. The current report summarizes the major learning points from this meeting. It also identifies areas where there is gap of knowledge, thereby identifying the research agenda for the near future.
Identifiants
pubmed: 35226643
doi: 10.1097/MPG.0000000000003341
pii: 00005176-202203000-00006
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e45-e56Informations de copyright
Copyright © 2021 by European Society for Pediatric Gastroenterology, Hepatology, and Nutrition and North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition.
Déclaration de conflit d'intérêts
The authors report no conflicts of interest.
Références
Squires RH Jr, Shneider BL, Bucuvalas J, et al. Acute liver failure in children: the first 348 patients in the pediatric acute liver failure study group. J Pediatr 2006; 148:652–658.
Trey C, Davidson LS. Popper H, Schaffner F. The management of fulminant hepatic failure. Progress in Liver Disease . New York: Grune & Stratton; 1970. 282–298.
Squires JE, Rudnick DA, Hardison RM, et al. Liver transplant listing in pediatric acute liver failure: practices and participant characteristics. Hepatology 2018; 68:2338–2347.
Narkewicz MR, Horslen S, Hardison RM, et al. Pediatric Acute Liver Failure Study Group. A learning collaborative approach increases specificity of diagnosis of acute liver failure in pediatric patients. Clin Gastroenterol Hepatol 2018; 16:1801.e3–1810.e3.
Schwarz KB, Dell Olio D, Lobritto SJ, et al. Pediatric Acute Liver Failure Study Group. Analysis of viral testing in nonacetaminophen pediatric acute liver failure. J Pediatr Gastroenterol Nutr 2014; 59:616–623.
Feldman AG, Sokol RJ, Hardison RM, et al. Pediatric Acute Liver Failure Study Group. Lactate and lactate: pyruvate ratio in the diagnosis and outcomes of pediatric acute liver failure. J Pediatr 2017; 182:217.e3–222.e3.
Narkewicz MR, Horslen S, Belle SH, et al. Pediatric Acute Liver Failure Study Group. Prevalence and significance of autoantibodies in children with acute liver failure. J Pediatr Gastroenterol Nutr 2017; 64:210–217.
Nicastro E, D’Antiga L. Next generation sequencing in pediatric hepatology and liver transplantation. Liver Transpl 2018; 24:282–293.
Li R, Belle SH, Horslen S, et al. Pediatric Acute Liver Failure Study Group. Clinical course among cases of acute liver failure of indeterminate diagnosis. J Pediatr 2016; 171:163.e1–3–170.e1–3.
Devictor D, Tissieres P, Afanetti M, et al. Acute liver failure in children. Clin Res Hepatol Gastroenterol 2011; 35:430–437.
Pan X, Kelly S, Melin-Aldana H, et al. Novel mechanism of fetal hepatocyte injury in congenital alloimmune hepatitis involves the terminal complement cascade. Hepatology 2010; 51:2061–2068.
Lee WS, Sokol RJ. Mitochondrial hepatopathies: advances in genetics, therapeutic approaches, and outcomes. J Pediatr 2013; 163:942–948.
Bigot A, Tchan MC, Thoreau B, et al. Liver involvement in urea cycle disorders: a review of the literature. J Inherit Metab Dis 2017; 40:757–769.
Brassier A, Ottolenghi C, Boutron A, et al. Dihydrolipoamide dehydrogenase deficiency: a still overlooked cause of recurrent acute liver failure and Reye-like syndrome. Mol Genet Metab 2013; 109:28–32.
Casey JP, Slattery S, Cotter M, et al. Clinical and genetic characterisation of infantile liver failure syndrome type 1, due to recessive mutations in LARS. J Inherit Metab Dis 2015; 38:1085–1092.
Lenz D, Smith DEC, Crushell E, et al. Genotypic diversity and phenotypic spectrum of infantile liver failure syndrome type 1 due to variants in LARS1. Genet Med 2020; 22:1863–1873.
Kopajtich R, Murayama K, Janecke AR, et al. Biallelic IARS mutations cause growth retardation with prenatal onset, intellectual disability, muscular hypotonia, and infantile hepatopathy. Am J Hum Genet 2016; 99:414–422.
Antonellis A, Green ED. The role of aminoacyl-tRNA synthetases in genetic diseases. Annu Rev Genomics Hum Genet 2008; 9:87–107.
Hadchouel A, Wieland T, Griese M, et al. Biallelic mutations of methionyl-tRNA synthetase cause a specific type of pulmonary alveolar proteinosis prevalent on Réunion Island. Am J Hum Genet 2015; 96:826–831.
Julier C, Nicolino M. Wolcott-Rallison syndrome. Orphanet J Rare Dis 2010; 5:29.
Schmidt WM, Rutledge SL, Schüle R, et al. Disruptive SCYL1 mutations underlie a syndrome characterized by recurrent episodes of liver failure, peripheral neuropathy, cerebellar atrophy, and ataxia. Am J Hum Genet 2015; 97:855–861.
Lenz D, McClean P, Kansu A, et al. SCYL1 variants cause a syndrome with low γ-glutamyl-transferase cholestasis, acute liver failure, and neurodegeneration (CALFAN). Genet Med 2018; 20:1255–1265.
Cousin MA, Conboy E, Wang JS, et al. RINT1 bi-allelic variations cause infantile-onset recurrent acute liver failure and skeletal abnormalities. Am J Hum Genet 2019; 105:108–121.
Haack TB, Staufner C, Köpke MG, et al. Biallelic mutations in NBAS cause recurrent acute liver failure with onset in infancy. Am J Hum Genet 2015; 97:163–169.
Staufner C, Haack TB, Köpke MG, et al. Recurrent acute liver failure due to NBAS deficiency: phenotypic spectrum, disease mechanisms, and therapeutic concepts. J Inherit Metab Dis 2016; 39:3–16.
Staufner C, Peters B, Wagner M, et al. Defining clinical subgroups and genotype-phenotype correlations in NBAS-associated disease across 110 patients. Genet Med 2020; 22:610–621.
Raote I, Ortega-Bellido M, Santos AJ, et al. TANGO1 builds a machine for collagen export by recruiting and spatially organizing COPII, tethers and membranes. Elife 2018; 7:e32723.
Mc Kiernan PJ. Recent advances in liver transplantation for metabolic disease. J Inherit Metab Dis 2017; 4:491–495.
Alam S, Khanna R, Sood V, et al. Profile and outcome of first 109 cases of paediatric acute liver failure at a specialized paediatric liver unit in India. Liver Int 2017; 37:1508–1514.
Hedeland RL, Andersen J, Askbo N, et al. Early predictors of severe acetaminophen-induced hepatotoxicity in a paediatric population referred to a tertiary paediatric department. Acta Paediatr 2014; 103:1179–1186.
Amin M, Harpavat S, Leung D. Drug-induced liver injury in children. Curr Opin Pediatr 2015; 27:625–633.
DiPaola F, Molleston JP, Gu J, et al. US Drug Induced Liver Injury Network. Antimicrobials and antiepileptics are the leading causes of idiosyncratic drug-induced liver Injury in American children. J Pediatr Gastroenterol Nutr 2019; 69:152–159.
Ocete-Hita E, Salmerón-Fernández M, Urrutia-Maldonado E, et al. Analysis of immunogenetic factors in idiosyncratic drug-induced liver injury in the pediatric population. J Pediatr Gastroenterol Nutr 2017; 64:742–747.
Squires JE, McKiernan P, Squires RH. Acute liver failure: an update. Clin Liver Dis 2018; 22:773–805.
Andrade RJ, Chalasani N, Björnsson ES, et al. Drug-induced liver injury. Nat Rev Dis Primers 2019; 5:58.
Henter JI, Horne A, Aricó M, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 2007; 48:124–131.
Schwartzberg PL, Mueller KL, Qi H, et al. SLAM receptors and SAP influence lymphocyte interactions, development and function. Nat Rev Immunol 2009; 9:39–46.
Chinn IK, Eckstein OS, Peckham-Gregory EC, et al. Genetic and mechanistic diversity in pediatric hemophagocytic lymphohistiocytosis. Blood 2018; 132:89–100.
Tesi B, Bryceson YT. HLH: genomics illuminates pathophysiological diversity. Blood 2018; 132:5–7.
Bergsten E, Horne A, Aricó M, et al. Confirmed efficacy of etoposide and dexamethasone in HLH treatment: long-term results of the cooperative HLH-2004 study. Blood 2017; 130:2728–2738.
Sood V, Lal BB, Gupta E, et al. Hepatitis A virus-related pediatric liver disease burden and its significance in the Indian subcontinent. Indian Pediatr 2019; 56:741–744.
Lal BB, Sood V, Snehavardhan P, et al. A novel, bedside, etiology specific prognostic model (Peds-HAV) in hepatitis A induced pediatric acute liver failure. Hepatol Int 2020; 14:483–490.
Indolfi G, Abdel-Hady M, Bansal S, et al. Management of hepatitis B virus infection and prevention of hepatitis B virus reactivation in children with acquired immunodeficiencies or undergoing immune suppressive, cytotoxic, or biological modifier therapies. J Pediatr Gastroenterol Nutr 2020; 70:527–538.
Shanmugam NP, Bansal S, Greenough A, et al. Neonatal liver failure: aetiologies and management--state of the art. Eur J Pediatr 2011; 170:573–581.
Sundaram SS, Alonso EM, Narkewicz MR, et al. Pediatric Acute Liver Failure Study Group. Characterization and outcomes of young infants with acute liver failure. J Pediatr 2011; 159:813.e1–818.e1.
Ng VL, Li R, Loomes KM, et al. Outcomes of children with and without hepatic encephalopathy from the Pediatric Acute Liver Failure (PALF) Study Group. J Pediatr Gastroenterol Nutr 2016; 63:357–364.
Weiss N, Jalan R, Thabut D. Understanding hepatic encephalopathy. Intensive Care Med 2018; 44:231–234.
Sheikh MF, Unni N, Agarwal B. Neurological monitoring in acute liver failure. J Clin Exp Hepatol 2018. 441–447.
Zacharias HD, Zacharias AP, Gluud LL, et al. Pharmacotherapies that specifically target ammonia for the prevention and treatment of hepatic encephalopathy in adults with cirrhosis. Cochrane Database Syst Rev 2019; 6:CD012334.
Alshami F, Alshammari K, Belley-Cote E, et al. Extracorporeal liver support in patients with liver failure: a systematic review and meta-analysis of randomized trials. Intensive Care Med 2020; 46:1–16.
Jain V, Dhawan A. Extracorporeal liver support systems in paediatric liver failure. J Pediatr Gastroenterol Nutr 2017; 64:855–863.
Deep A, Stewart CE, Dhawan A, et al. Effect of continuous renal replacement therapy on outcome in pediatric acute liver failure. Crit Care Med 2016; 44:1910–1919.
Lisman T, Porte RJ. Rebalanced hemostasis in patients with liver disease: evidence and clinical consequences. Blood 2010; 116:878–885.
Lisman T, Stravitz RT. Rebalanced hemostasis in patients with acute liver failure. Semin Thromb Hemost 2015; 41:468–473.
Stravitz RT, Ellerbe C, Durkalski V, et al. Acute Liver Failure Study Group. Bleeding complications in acute liver failure. Hepatology 2018; 67:1931–1942.
Stravitz RT, Ellerbe C, Durkalski V, et al. Acute Liver Failure Study Group. Thrombocytopenia is associated with multi-organ system failure in patients with acute liver failure. Clin Gastroenterol Hepatol 2016; 14:613.e4–620.e4.
Hugenholtz GC, Adelmeijer J, Meijers JC, et al. An unbalance between von Willebrand factor and ADAMTS13 in acute liver failure: implications for hemostasis and clinical outcome. Hepatology 2013; 58:752–761.
Driever EG, Stravitz RT, Zhang J, et al. VWF/ADAMTS13 imbalance, but not global coagulation or fibrinolysis, is associated with outcome and bleeding in acute liver failure. Hepatology 2021; 73:1882–1891.
Lisman T, Bakhtiari K, Adelmeijer J, et al. Intact thrombin generation and decreased fibrinolytic capacity in patients with acute liver injury or acute liver failure. J Thromb Haemost 2012; 10:1312–1319.
Ganey PE, Luyendyk JP, Newport SW, et al. Role of the coagulation system in acetaminophen-induced hepatotoxicity in mice. Hepatology 2007; 46:1177–1786.
Moreau R, Jalan R, Gines P, et al. CANONIC Study Investigators of the EASL-CLIF Consortium. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. Gastroenterology 2013; 144:1426–1437. e1–9.
Perricone G, Jalan R. Acute-on-chronic liver failure: a distinct clinical syndrome that has reclassified cirrhosis. Clin Liver Dis (Hoboken) 2019; 14:171–175.
Triantafyllou E, Woollard KJ, McPhail MJW, et al. The role of monocytes and macrophages in acute and acute-on-chronic liver failure. Front Immunol 2018; 9:2948.
Trebicka J, Amoros A, Pitarch C, et al. Addressing profiles of systemic inflammation across the different clinical phenotypes of acutely decompensated cirrhosis. Front Immunol 2019; 10:476.
Di Giorgio A, Nicastro E, Dalla Rosa D, et al. Transplant-free survival in chronic liver disease presenting as acute liver failure in childhood. Transplantation 2019; 103:544–551.
Mendizabal M, Dip M, Demirdjian E, et al. Changing etiologies and prognostic factors in pediatric acute liver failure. Liver Transpl 2020; 26:268–275.
Lal J, Thapa BR, Rawal P, et al. Predictors of outcome in acute-on-chronic liver failure in children. Hepatol Int 2011; 5:693–697.
Jagadisan B, Srivastava A, Yachha SK, et al. Acute on chronic liver disease in children from the developing world: recognition and prognosis. J Pediatr Gastroenterol Nutr 2012; 54:77–82.
Alam S, Lal BB, Sood V, et al. Pediatric acute-on-chronic liver failure in a specialized liver unit: prevalence, profile, outcome, and predictive factors. J Pediatr Gastroenterol Nutr 2016; 63:400–405.
D'Souza R, Grammatikopoulos T, Pradhan A, et al. Acute-on-chronic liver failure in children with biliary atresia awaiting liver transplantation. Pediatr Transplant 2019; 23:e13339.
Chavarria L, Alonso J, Rovira A, et al. Neuroimaging in acute liver failure. Neurochem Int 2011; 59:1175–1180.
Hudak A, Peng L, Marquez de la Plata C, et al. Cytotoxic and vasogenic cerebral oedema in traumatic brain injury: assessment with FLAIR and DWI imaging. Brain Inj 2014; 28:1602–1609.
McPhail MJ, Patel NR, Taylor-Robinson SD. Brain imaging and hepatic encephalopathy. Clin Liver Dis 2012; 16:57–72.
Lin D, Crawford T, Barker P. Proton MR spectroscopy in the diagnostic evaluation of suspected mitochondrial disease. AJNR 2003; 24:33–141.
Rajajee V, Williamson CA, Fontana RJ, et al. Noninvasive intracranial pressure assessment in acute liver failure. Neurocrit Care 2018; 29:280–290.
Williams H, McKiernan P, Kelly D, et al. Magnetic resonance imaging in neonatal hemochromatosis—are we there yet? Liver Transpl 2006; 12:1725.
Nielsen HB, Tofteng F, Wang LP, et al. Cerebral oxygenation determined by near-infrared spectrophotometry in patients with fulminant hepatic failure. J Hepatol 2003; 38:188–192.
Lee WM, Hynan LS, Rossaro L, et al. Acute Liver Failure Study Group. Intravenous N -acetylcysteine improves transplant-free survival in early stage non-acetaminophen acute liver failure. Gastroenterology 2009; 137:856.e1–864.e1.
Vaquero J, Fontana RJ, Larson AM, et al. Complications and use of intracranial pressure monitoring in patients with acute liver failure and severe encephalopathy. Liver Transpl 2005; 11:1581–1589.
Audimoolam VK, McPhail MJ, Willars C, et al. Predicting fluid responsiveness in acute liver failure: a prospective study. Anesth Analg 2017; 124:480–486.
Squires RH, Dhawan A, Alonso E, et al. Pediatric Acute Liver Failure Study Group. Intravenous N -acetylcysteine in pediatric patients with nonacetaminophen acute liver failure: a placebo-controlled clinical trial. Hepatology 2013; 57:1542–1549.
Sasbón JS, Buamscha D. Acute liver failure. Pediatr Crit Care Med 2012; 13:114–115.
Chen PH, Chan KC, Liao MH, et al. Accuracy of dynamic preload variables for predicting fluid responsiveness in patients with pediatric liver cirrhosis: a prospective study. Pediatr Anesth 2020; 30:455–461.
Bhatia V, Batra Y, Acharya SK. Prophylactic phenytoin does not improve cerebral edema or survival in acute liver failure - a controlled clinical trial. Hepatology 2004; 41:89–96.
Murphy N, Auzinger G, Bernel W, et al. The effect of hypertonic sodium chloride on intracranial pressure in patients with acute liver failure. Hepatology 2004; 39:464–470.
Demetriou AA, Brown RS Jr, Busuttil RW, et al. Prospective, randomized, multicenter, controlled trial of a bioartificial liver in treating acute liver failure. Ann Surg 2004; 239:660–667. discussion 667–70.
Acharya SK, Bhatia V, Sreenivas V, et al. Efficacy of L -ornithine L -aspartate in acute liver failure: a double-blind, randomized, placebo-controlled study. Gastroenterology 2009; 136:2159–2168.
Saliba F, Camus C, Durand F, et al. Albumin dialysis with a noncell artificial liver support device in patients with acute liver failure: a randomized, controlled trial. Ann Intern Med 2013; 159:522–531.
Larsen FS, Schmidt LE, Bernsmeier C, et al. High-volume plasma exchange in patients with acute liver failure: an open randomised controlled trial. J Hepatol 2016; 64:69–78.